Atlas Trials

Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity

Clinical trial NCT00800462 · COMPLETED

Trial details

NCT number
NCT00800462
Sponsor
Toronto Rehabilitation Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Spinal Cord InjuryNeurogenic Detrusor Overactivity
Start date
2008-03-01
Primary completion
2012-06-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.